SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cell Genesys, Inc. (Nasdaq:CEGE) today reported financial results for the third quarter ended September 30, 2008. The net loss for the quarter ended September 30, 2008, was $8.4 million ($0.10 per fully diluted share), compared to a net loss of $34.5 million ($0.46 per fully diluted share) for the corresponding period in 2007. The company ended the quarter with approximately $151 million in cash, cash equivalents and short-term investments.
